| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0008 |